2019
DOI: 10.1042/bst20190246
|View full text |Cite
|
Sign up to set email alerts
|

Elucidating cyclic AMP signaling in subcellular domains with optogenetic tools and fluorescent biosensors

Abstract: The second messenger 3′,5′-cyclic nucleoside adenosine monophosphate (cAMP) plays a key role in signal transduction across prokaryotes and eukaryotes. Cyclic AMP signaling is compartmentalized into microdomains to fulfil specific functions. To define the function of cAMP within these microdomains, signaling needs to be analyzed with spatio-temporal precision. To this end, optogenetic approaches and genetically encoded fluorescent biosensors are particularly well suited. Synthesis and hydrolysis of cAMP can be … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 314 publications
(388 reference statements)
0
5
0
Order By: Relevance
“…To scrutinize bPAC and LAPD activity during nanobody-binding in a ciliary context, we aimed to use cAMP biosensors, which can be targeted to the primary cilium. However, all reported biosensors spectrally overlap with the LAPD activation spectrum to some extend ( Klausen et al, 2019 ). For bPAC, one biosensor is well suited to simultaneously activate bPAC and measure changes in cAMP levels: the red-shifted cAMP biosensor R-FlincA ( Ohta et al, 2018 ).…”
Section: Resultsmentioning
confidence: 99%
“…To scrutinize bPAC and LAPD activity during nanobody-binding in a ciliary context, we aimed to use cAMP biosensors, which can be targeted to the primary cilium. However, all reported biosensors spectrally overlap with the LAPD activation spectrum to some extend ( Klausen et al, 2019 ). For bPAC, one biosensor is well suited to simultaneously activate bPAC and measure changes in cAMP levels: the red-shifted cAMP biosensor R-FlincA ( Ohta et al, 2018 ).…”
Section: Resultsmentioning
confidence: 99%
“…Recently, the single-FP cAMP indicator cADDis was used to detect cAMP level changes upon the stimulation of the ligand of Gs or Gi protein-coupled GPCRs using automated microscope methods ( Tewson et al, 2016 ; Clayton, 2018 ), suggesting its potential capabilities in HCS. Since G-Flamp2 has a higher affinity for cAMP ( K d of 1.9 μM vs. 10–100 μM) and larger fluorescence change (ΔF/F 0 of 13 vs. −0.55) than cADDis ( Klausen et al, 2019 ), and a relatively high brightness, G-Flamp2 would be more suitable for HCS to identify and evaluate the effect of candidate compounds targeting GPCR-cAMP signaling pathways in drug discovery.…”
Section: Discussionmentioning
confidence: 99%
“…Taking advantage of the progress reached in animal systems, many other strategies and their combination may help in elucidating cAMP signalling in plant systems. Indeed, optogenetic approaches and genetically encoded fluorescent biosensors are effectively used to monitor and modulate cAMP levels [ 141 , 142 ]. Photoactivated ACs and light-regulated PDEs, or even their association, are successfully used in animal cells [ 143 , 144 ].…”
Section: Discussionmentioning
confidence: 99%